We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PVTB
451
DELISTED
PrivateBancorp Inc
PVTB
| $346K | 0.01% |
8,956
| – | – |
2013 Q2
11 quarters
|
|
452
Exelon
EXC
$43.8B
| $343K | 0.01% |
13,424
+610
| +5% | +$13.7K |
2013 Q2
11 quarters
|
|
453
First Solar
FSLR
$19.2B
| $337K | 0.01% |
+4,915
| New | +$329K |
2016 Q1
0 quarters
|
|
454
Paychex
PAYX
$39.4B
| $335K | 0.01% |
6,201
+199
| +3% | +$10K |
2014 Q1
8 quarters
|
|
455
CHS Inc Class B Series 4 Preferred Stock
CHSCL
$520M
| $334K | 0.01% |
12,000
| – | – |
2015 Q1
4 quarters
|
|
456
J.M. Smucker
SJM
$13.5B
| $330K | 0.01% |
2,541
-69
| -3% | -$8.7K |
2014 Q1
8 quarters
|
|
|
CLR
457
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $329K | 0.01% |
10,828
+1,883
| +21% | +$42.5K |
2013 Q2
11 quarters
|
|
458
AptarGroup
ATR
$7.9B
| $326K | 0.01% |
4,154
| – | – |
2013 Q2
11 quarters
|
|
459
Franklin Electric
FELE
$4.45B
| $322K | 0.01% |
10,000
-145
| -1% | -$4.12K |
2013 Q2
11 quarters
|
|
460
Target
TGT
$71.2B
| $320K | 0.01% |
3,888
-397
| -9% | -$30K |
2013 Q2
11 quarters
|
|
|
UWTI
461
DELISTED
VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9,
UWTI
| $320K | 0.01% |
+15,051
| New | +$321K |
2016 Q1
0 quarters
|
|
462
American International
AIG
$41.4B
| $318K | 0.01% |
5,882
-359
| -6% | -$19.4K |
2015 Q3
2 quarters
|
|
463
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $318K | 0.01% |
11,732
-8,276
| -41% | -$209K |
2013 Q2
11 quarters
|
|
464
WisdomTree
WT
$3.27B
| $315K | 0.01% |
27,551
-5,093
| -16% | -$61.1K |
2015 Q1
4 quarters
|
|
465
VanEck Gold Miners ETF
GDX
$26.1B
| $304K | 0.01% |
+15,229
| New | +$262K |
2016 Q1
0 quarters
|
|
466
Barrick Mining
B
$66.7B
| $304K | 0.01% |
22,385
+1,875
| +9% | +$21.8K |
2015 Q3
2 quarters
|
|
467
Morgan Stanley
MS
$286B
| $303K | 0.01% |
+12,127
| New | +$309K |
2016 Q1
0 quarters
|
|
468
East-West Bancorp
EWBC
$17.3B
| $298K | 0.01% |
9,170
-995,264
| -99% | -$32.5M |
2014 Q4
5 quarters
|
|
469
State Street
STT
$46B
| $298K | 0.01% |
5,092
-13
| -0.3% | -$738 |
2013 Q2
11 quarters
|
|
470
Ford
F
$49.1B
| $295K | 0.01% |
21,843
+1,208
| +6% | +$15.2K |
2015 Q3
2 quarters
|
|
471
American Electric Power
AEP
$67.7B
| $294K | 0.01% |
4,424
-357
| -7% | -$22.1K |
2013 Q2
11 quarters
|
|
472
iShares Russell 1000 Growth ETF
IWF
$127B
| $292K | 0.01% |
11,704
-652
| -5% | -$15.4K |
2015 Q2
3 quarters
|
|
473
ResMed
RMD
$34.1B
| $292K | 0.01% |
5,050
| – | – |
2013 Q2
11 quarters
|
|
474
Clorox
CLX
$10.4B
| $290K | 0.01% |
2,302
-8
| -0.3% | -$1.02K |
2014 Q2
7 quarters
|
|
475
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.5B
| $289K | 0.01% |
5,450
+1,099
| +25% | +$55.8K |
2014 Q4
5 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.